Priyanka Chopra revealed her grandmother's secret to youthful skin: coconut oil. This natural ingredient combats microbes and reduces infla...

A popular home hack of adding essential oils to toilet bowls for odor control is questioned by science. While these oils offer a pleasant s...

Integrative lifestyle expert Luke Coutinho highlights beetroot juice as a simple yet powerful dietary addition to combat heart health risks...

In a fascinating study, scientists from Johns Hopkins and the University of Mississippi analysed the presence of inflammatory molecules in ...

The skin is the largest organ in the body. It has an average area of about 20 square feet -- that's the size of a 4' by 5' room! Its outerm...

Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical...

The therapeutic, described in the journal Cell Reports, is called TAT CARMIL1, and is actually a combination of two naturally occurring sma...

Global pharma and life sciences major Bayer and domestic drug discovery firm Curadev have signed a research collaboration and licence agree...

Scientists, including one of Indian-origin, have identified the key inflammatory mechanisms linked to type 1 diabetes and obesity-related k...

Malaria parasites cause an inflammatory reaction that sabotages our body's ability to protect itself against the deadly disease, scientists...

Before trying the experiments the team ran simulations on the Raijin supercomputer, which indicated that their method had potential.

The company is expecting an additional payment to support the advancement of the programme, Glenmark Pharmaceuticals said.

The research effort combined with good performance in its generics business has made investors lap up its stock in recent quarters.

Glenmark Pharmaceuticals on Wednesday said it has started Phase-IIb human trials of its 'Revamilast' molecule.

Drug maker Glenmark Pharmaceuticals said its candidate for neuropathic, osteoarthritis and other inflammatory pain GRC 10693, is entering p...

Ranbaxy and UK major Glaxosmithkline (GSK) plan to begin clinical trials of an anti-inflammatory molecule by the end of the year.

Pharmaceuticals major Dr Reddy's Laboratories and its UK-based partner Argenta Discovery on Monday said they have selected the first candid...